This proposal requests continued support for the Medical Scientist Training Program (MSTP) at Vanderbilt University School of Medicine. The primary goal of the Vanderbilt MSTP is to identify, mentor, and foster the careers of future leaders in academic medicine who are dedicated to improving human health through discovery. The program is based on rigorous training in clinical medicine and scientific inquiry. Successful completion of the MSTP leads to both M.D. and Ph.D. degrees. Core elements of the program developed specifically for dual-degree students include a foundational course in research, literature-based seminar series, clinical preceptorship program, data club, leadership workshop, career development workshop, physician-scientist speaker series, and an annual retreat. Formal instruction in the responsible conduct of research is provided throughout the curriculum. MSTP students are assigned to one of four innovative advising colleges that provide a framework for academic counseling by faculty and peers. Current students play key roles in new student recruitment, program administration, and curriculum development. Seventy-two percent of our graduates with established careers hold academic or private-sector research positions, including two deans, four department chairs, and 24 full professors. More recent graduates have been placed in superb residencies and fellowships. The 92 current trainees come from 57 colleges and universities distributed across North America. The nationwide applicant pool results from concerted recruiting efforts, including those focused on the recruitment of students from groups underrepresented in medicine. In the current year, 380 applications have been received, from which 12 students will be selected to enter the incoming class. The proposed goal is to increase the size of the program to a steady state of 112 students over the next five years. Extramural research funding at Vanderbilt has increased from $389 million to $444 million since 2008. Research opportunities for MSTP trainees include established strengths in biomedical informatics, cancer biology, cell biology, clinical pharmacology, diabetes, neurosciences, toxicology, and vaccine science as well as new areas of emphasis in chemical and physical biology, drug discovery, genetics, imaging sciences, microbial pathogenesis, pharmacogenomics, and structural biology. As such, the educational environment for physician- scientists at Vanderbilt is outstanding. The proposal requests an increase in funded positions to 24 for the five- year project period. Ongoing support for the Vanderbilt MSTP is justified based on the strength of the applicant pool, numerous opportunities for physician-scientist training, an institutional commitment to the education of leaders in biomedical research, and success of our graduates in academic medicine.

Public Health Relevance

The Vanderbilt Medical Scientist Training Program supports the training of physician-scientists who seek to improve human health through basic, translational, or clinical research. The broad public health significance of this program will be realized through the academic and scholarly accomplishments of the trainees, with connections to both the direct treatment of patients in the clinical setting and the discovery of basic disease mechanisms and new therapeutic agents.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
2T32GM007347-36
Application #
8607649
Study Section
(TWD)
Program Officer
Preusch, Peter
Project Start
1977-07-01
Project End
2019-06-30
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
36
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Pediatrics
Type
Schools of Medicine
DUNS #
City
Nashville
State
TN
Country
United States
Zip Code
37212
Dovey, Cole M; Diep, Jonathan; Clarke, Bradley P et al. (2018) MLKL Requires the Inositol Phosphate Code to Execute Necroptosis. Mol Cell 70:936-948.e7
Jonathan, Sumeeth V; Grissom, William A (2018) Volumetric MRI thermometry using a three-dimensional stack-of-stars echo-planar imaging pulse sequence. Magn Reson Med 79:2003-2013
Koethe, John R; McDonnell, Wyatt; Kennedy, Arion et al. (2018) Adipose Tissue is Enriched for Activated and Late-Differentiated CD8+ T Cells and Shows Distinct CD8+ Receptor Usage, Compared With Blood in HIV-Infected Persons. J Acquir Immune Defic Syndr 77:e14-e21
Donahue, Manus J; Achten, Eric; Cogswell, Petrice M et al. (2018) Consensus statement on current and emerging methods for the diagnosis and evaluation of cerebrovascular disease. J Cereb Blood Flow Metab 38:1391-1417
McKenna, Matthew T; Weis, Jared A; Quaranta, Vito et al. (2018) Variable Cell Line Pharmacokinetics Contribute to Non-Linear Treatment Response in Heterogeneous Cell Populations. Ann Biomed Eng 46:899-911
Kozek, Krystian A; Du, Yu; Sharma, Swagat et al. (2018) Discovery and Characterization of VU0529331, a Synthetic Small-Molecule Activator of Homomeric G Protein-Gated, Inwardly Rectifying, Potassium (GIRK) Channels. ACS Chem Neurosci :
Athmer, Jeremiah; Fehr, Anthony R; Grunewald, Matthew E et al. (2018) Selective Packaging in Murine Coronavirus Promotes Virulence by Limiting Type I Interferon Responses. MBio 9:
Sundermann, Alexandra C; Saum, Keith; Conrad, Kelsey A et al. (2018) Prognostic value of D-dimer and markers of coagulation for stratification of abdominal aortic aneurysm growth. Blood Adv 2:3088-3096
Burns, Michael C; Howes, Jennifer E; Sun, Qi et al. (2018) High-throughput screening identifies small molecules that bind to the RAS:SOS:RAS complex and perturb RAS signaling. Anal Biochem 548:44-52
Feng, QiPing; Wei, Wei-Qi; Chung, Cecilia P et al. (2018) Relationship between very low low-density lipoprotein cholesterol concentrations not due to statin therapy and risk of type 2 diabetes: A US-based cross-sectional observational study using electronic health records. PLoS Med 15:e1002642

Showing the most recent 10 out of 536 publications